{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:35:46Z","timestamp":1761561346984},"reference-count":9,"publisher":"Baishideng Publishing Group Inc.","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2009]]},"DOI":"10.3748\/wjg.15.2669","type":"journal-article","created":{"date-parts":[[2009,6,5]],"date-time":"2009-06-05T02:16:42Z","timestamp":1244168202000},"page":"2669","source":"Crossref","is-referenced-by-count":24,"title":["Ceftriaxone-induced toxic hepatitis"],"prefix":"10.3748","volume":"15","author":[{"given":"Erdal","family":"Peker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eren","family":"Cagan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murat","family":"Dogan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Hussaini SH, Farrington EA. Idiosyncratic drug-induced liver injury: an overview. Expert Opin Drug Saf 2007;6:673-684.","DOI":"10.1517\/14740338.6.6.673"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Bell MJ, Stockwell DC, Luban NL, Shirey RS, Shaak L, Ness PM, Wong EC. Ceftriaxone-induced hemolytic anemia and hepatitis in an adolescent with hemoglobin SC disease. Pediatr Crit Care Med 2005;6:363-366.","DOI":"10.1097\/01.PCC.0000161285.12396.FF"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Longo F, Hastier P, Buckley MJ, Chichmanian RM, Delmont JP. Acute hepatitis, autoimmune hemolytic anemia, and erythroblastocytopenia induced by ceftriaxone. Am J Gastroenterol 1998;93:836-837.","DOI":"10.1111\/j.1572-0241.1998.239_a.x"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Nadelman RB, Arlin Z, Wormser GP. Life-threatening complications of empiric ceftriaxone therapy for 'seronegative Lyme disease'. South Med J 1991;84:1263-1265.","DOI":"10.1097\/00007611-199110000-00024"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Polson JE. Hepatotoxicity due to antibiotics. Clin Liver Dis 2007;11:549-561, vi.","DOI":"10.1016\/j.cld.2007.06.009"},{"key":"ref6","unstructured":"Robles M, Andrade RJ. [Hepatotoxicity by antibiotics: update in 2008]. Rev Esp Quimioter 2008;21:224-233."},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Brinker AD, Wassel RT, Lyndly J, Serrano J, Avigan M, Lee WM, Seeff LB. Telithromycin-associated hepatotoxicity: Clinical spectrum and causality assessment of 42 cases. Hepatology 2009;49:250-257.","DOI":"10.1002\/hep.22620"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Chen J, Ahmad J. Cefdinir-induced hepatotoxicity: potential hazards of inappropriate antibiotic use. J Gen Intern Med 2008;23:1914-1916.","DOI":"10.1007\/s11606-008-0758-y"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Roy PD, Majumder M, Roy B. Pharmacogenomics of anti-TB drugs-related hepatotoxicity. Pharmacogenomics 2008;9:311-321.","DOI":"10.2217\/14622416.9.3.311"}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v15\/i21\/2669.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T16:53:33Z","timestamp":1558371213000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v15\/i21\/2669.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"references-count":9,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.15.2669","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2009]]}}}